Void contract could lead to Coloplast acquisition
Coloplast has withdrawn a number of products from the market lately, which has led a US supplier to cancel its contract with the medtech group. Coloplast has sued and currently considers whether a new partnership deal or an acquisition should help the company in the field in question.
BY STEFAN SINGH KAILAY
LONDON
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Coloplast cancels commercial partnership
For abonnenter
Analysis: New Coloplast strategy could boost profit
For abonnenter
These products will drive growth in Coloplast
For abonnenter
